当前位置:首页 - 行情中心 - 丰倍生物(603334) - 财务分析 - 现金流量表

丰倍生物

(603334)

  

流通市值:14.43亿  总市值:66.67亿
流通股本:3105.36万   总股本:1.44亿

现金流量表

报告期2025-09-302025-06-302024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,185,678,509.881,525,126,387.582,018,702,887.391,176,883,101.88
  收到的税费返还38,503,756.8719,445,574.6948,299,157.228,282,825.84
  收到其他与经营活动有关的现金2,965,864.022,301,531.2713,922,176.7313,408,004.3
  经营活动现金流入小计2,227,148,130.771,546,873,493.542,080,924,221.321,218,573,932.02
  购买商品、接受劳务支付的现金2,208,195,491.831,463,315,722.681,936,006,070.631,175,282,433.28
  支付给职工以及为职工支付的现金41,612,462.3534,292,528.9354,759,715.1443,867,847.42
  支付的各项税费88,646,867.6344,763,788.4637,942,793.1529,039,449.55
  支付其他与经营活动有关的现金21,446,147.6211,980,515.5129,785,314.9129,058,281.79
  经营活动现金流出小计2,359,900,969.431,554,352,555.582,058,493,893.831,277,248,012.04
  经营活动产生的现金流量净额-132,752,838.66-7,479,062.0422,430,327.49-58,674,080.02
二、投资活动产生的现金流量:
  收回投资收到的现金--5,666,1605,666,160
  处置固定资产、无形资产和其他长期资产收回的现金净额98,439.8398,439.83169,202.4395,165.39
  收到的其他与投资活动有关的现金2,122,257.4401,869,698.241,400,468.22
  投资活动现金流入小计2,220,697.2798,439.837,705,060.677,161,793.61
  购建固定资产、无形资产和其他长期资产支付的现金18,552,431.6714,991,278.8379,533,183.5871,124,383.65
  投资支付的现金--5,666,1605,666,160
  支付其他与投资活动有关的现金3,770,423.9180,176.971,424,970.32904,973.72
  投资活动现金流出小计22,322,855.5715,171,455.886,624,313.977,695,517.37
  投资活动产生的现金流量净额-20,102,158.3-15,073,015.97-78,919,253.23-70,533,723.76
三、筹资活动产生的现金流量:
  取得借款收到的现金254,500,000193,500,000315,200,000260,200,000
  收到其他与筹资活动有关的现金17,983,195.0417,983,195.047,342,890.876,591,618.3
  筹资活动现金流入小计272,483,195.04211,483,195.04322,542,890.87266,791,618.3
  偿还债务支付的现金182,100,000154,250,000242,856,891185,106,891
  分配股利、利润或偿付利息支付的现金6,667,052.14,865,710.7910,632,771.997,075,181.72
  支付其他与筹资活动有关的现金2,321,0001,721,0004,146,0003,262,500
  筹资活动现金流出小计191,088,052.1160,836,710.79257,635,662.99195,444,572.72
  筹资活动产生的现金流量净额81,395,142.9450,646,484.2564,907,227.8871,347,045.58
四、汇率变动对现金及现金等价物的影响2,291,548.322,093,466.524,651,292.152,330,261.99
五、现金及现金等价物净增加额-69,168,305.730,187,872.7613,069,594.29-55,530,496.21
  加:期初现金及现金等价物余额150,791,166.09150,791,166.09137,721,571.8137,721,571.8
  期末现金及现金等价物余额81,622,860.39180,979,038.85150,791,166.0982,191,075.59
补充资料:
  净利润-85,063,308.58123,819,879.98-
  资产减值准备-755,770.82734,567.77-
  固定资产和投资性房地产折旧-10,947,077.4315,413,227.93-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-10,947,077.4315,413,227.93-
  无形资产摊销-606,971.99815,641.82-
  长期待摊费用摊销-718,752.812,245,630.86-
  处置固定资产、无形资产和其他长期资产的损失--729.51-48,776.73-
  固定资产报废损失-70,897.9860,184.56-
  公允价值变动损失--225,846.75340,708.35-
  财务费用-1,278,611.591,347,058.95-
  投资损失---699,765.17-
  递延所得税--653,358.14-3,421,927.97-
  其中:递延所得税资产减少--503,674.68-4,145,134.12-
    递延所得税负债增加--149,683.46723,206.15-
  存货的减少--13,722,336.4-44,272,141.1-
  经营性应收项目的减少--107,062,749.42-118,187,584.41-
  经营性应付项目的增加-14,547,083.0632,808,603.16-
  其他--4,932,801.663,284,635.49-
  现金的期末余额-180,979,038.85150,791,166.09-
  减:现金的期初余额-150,791,166.09137,721,571.8-
  现金及现金等价物的净增加额-30,187,872.7613,069,594.29-
公告日期2025-11-042025-10-172025-06-302025-11-04
审计意见(境内)标准无保留意见标准无保留意见
TOP↑